These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Prolonged QT(U) interval: association with disease and use of drugs]. Laakso M; Aberg A; Savola J; Pentikäinen PJ; Pyörälä K Duodecim; 1986; 102(4):235-42. PubMed ID: 3956410 [No Abstract] [Full Text] [Related]
4. [Dynamics of ventricular repolarisation]. Leenhardt A; Maison-Blanche P; Denjoy I; Neyroud N; Pellerin D; Catuli D; Thomas O; Coumel P Arch Mal Coeur Vaiss; 1995 Dec; 88 Spec No 5():27-33. PubMed ID: 8729297 [TBL] [Abstract][Full Text] [Related]
5. [Ventricular arrhythmias. A potential risk associated with the use of non-cardiovascular drugs prolonging the QT interval]. Calderone V; Cavero I Minerva Med; 2002 Jun; 93(3):181-97. PubMed ID: 12094149 [TBL] [Abstract][Full Text] [Related]
7. The long QT syndrome: when syncope is common to the young and the elderly. Futterman LG; Lemberg L Am J Crit Care; 1995 Sep; 4(5):405-12. PubMed ID: 7489046 [No Abstract] [Full Text] [Related]
8. Long QT interval resembling long QT syndrome in a newborn with electrolyte dysbalance. Ayangade-Johnson G; Villafane J J Ky Med Assoc; 2001 Jul; 99(7):285-7. PubMed ID: 11468869 [TBL] [Abstract][Full Text] [Related]
9. [Electrocardiographic changes in electrolyte inbalance. Part 2: Alterations in serum calcium (author's transl)]. So CS; Batrice L; Volger E Med Klin; 1975 Nov; 70(48):1966-8. PubMed ID: 1207632 [TBL] [Abstract][Full Text] [Related]
11. Effects of antiarrhythmic drugs on QT interval dispersion--relationship to antiarrhythmic action and proarrhythmia. Gillis AM Prog Cardiovasc Dis; 2000; 42(5):385-96. PubMed ID: 10768315 [TBL] [Abstract][Full Text] [Related]
12. Amiodarone-associated macroscopic T-wave alternans and torsade de pointes unmasking the inherited long QT syndrome. Wegener FT; Ehrlich JR; Hohnloser SH Europace; 2008 Jan; 10(1):112-3. PubMed ID: 18006559 [No Abstract] [Full Text] [Related]
13. [Psychiatric patients and QT interval monitoring]. Girardin F; Gaspoz JM Rev Med Suisse; 2007 Apr; 3(106):945-8. PubMed ID: 17575970 [TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic effect of parenteral magnesium on ventricular tachycardia associated with long QT syndrome. Kurita T Magnes Res; 1994 Jun; 7(2):155-7. PubMed ID: 7999530 [TBL] [Abstract][Full Text] [Related]
15. Drugs, QT interval abnormalities and ventricular arrhythmias. Thomas SH Adverse Drug React Toxicol Rev; 1994; 13(2):77-102. PubMed ID: 7918900 [No Abstract] [Full Text] [Related]
16. Arrhythmias in patients with drug toxicity, electrolyte, and endocrine disturbances. Commerford PJ; Lloyd EA Med Clin North Am; 1984 Sep; 68(5):1051-78. PubMed ID: 6387326 [TBL] [Abstract][Full Text] [Related]
17. Acquired long QT syndrome: Unequal regression of Amiodarone-induced repolarization lengthening. Raviña T; Raviña P; Gutierrez J Int J Cardiol; 2008 Mar; 124(3):395-9. PubMed ID: 17391786 [TBL] [Abstract][Full Text] [Related]
18. Effect of myocardial ischemia and type I antiarrhythmic drug therapy on exercise QT intervals. Gardner MJ; McCarthy DM; Josephson ME Can J Cardiol; 1985 Jan; 1(1):37-40. PubMed ID: 3850762 [TBL] [Abstract][Full Text] [Related]